Fabrinet Work in process increased by 15.8% to $544.22M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 67.7%, from $324.52M to $544.22M. Over 4 years (FY 2021 to FY 2025), Work in process shows an upward trend with a 21.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $174.65M | $190.96M | $198.50M | $205.51M | $217.64M | $268.08M | $294.45M | $321.91M | $305.63M | $248.92M | $249.87M | $260.97M | $266.11M | $276.78M | $304.48M | $324.52M | $377.74M | $417.35M | $469.93M | $544.22M |
| QoQ Change | — | +9.3% | +3.9% | +3.5% | +5.9% | +23.2% | +9.8% | +9.3% | -5.1% | -18.6% | +0.4% | +4.4% | +2.0% | +4.0% | +10.0% | +6.6% | +16.4% | +10.5% | +12.6% | +15.8% |
| YoY Change | — | — | — | — | +24.6% | +40.4% | +48.3% | +56.6% | +40.4% | -7.1% | -15.1% | -18.9% | -12.9% | +11.2% | +21.9% | +24.4% | +41.9% | +50.8% | +54.3% | +67.7% |
| % of Inventories | 41.4% | 41.0% | 40.9% | 45.4% | 39.1% | 50.8% | 54.9% | 58.1% | 58.8% | 56.6% | 60.2% | 57.5% | 57.4% | 62.8% | 62.2% | 61.1% | 65.0% | 57.8% | 58.8% | 62.1% |
| Share Change | — | -0.3pp | -0.1pp | +4.5pp | -6.3pp | +11.7pp | +4.1pp | +3.2pp | +0.7pp | -2.3pp | +3.7pp | -2.8pp | -0.0pp | +5.4pp | -0.6pp | -1.2pp | +3.9pp | -7.2pp | +1.0pp | +3.3pp |